|
|
||||||||
1 From the Department of Clinical Studies, University of Guelph, Guelph, Ontario, Canada; and 2 Laboratory of Retinal Cell Biology, Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland.
PURPOSE. To determine whether the volatile anesthetic halothane protects against light-induced photoreceptor degeneration in the rodent retina.
METHODS. Albino mice and rats were anesthetized with halothane and exposed to high levels of white or blue light. Nonanesthetized animals served as controls. Retinal morphology was assessed by light microscopy, and apoptosis of photoreceptor cells was verified by detection of fragmented genomic DNA and in situ staining of apoptotic nuclei (TUNEL assay). Rhodopsin regeneration after bleaching was determined by measuring rhodopsin levels in retinas of mice or rats at different time points in darkness.
RESULTS. Halothane anesthesia reversibly inhibited metabolic rhodopsin regeneration and thus prevented rhodopsin from absorbing high numbers of photons during light exposure. Consequently, photoreceptors of mice and rats anesthetized with halothane were completely protected against degeneration induced by white light. In remarkable contrast, however, halothane anesthesia did not protect against blue-lightinduced photoreceptor cell death.
CONCLUSIONS. After the initial bleach, halothane impeded photon absorption by rhodopsin by inhibiting metabolic rhodopsin regeneration. Apparently, the rhodopsin-mediated uptake of the critical number of photons to initiate white lightinduced retinal degeneration was prevented. In contrast, halothane did not protect the retina against blue light. Blue light can efficiently restore functional rhodopsin from bleaching intermediates through a process termed photoreversal of bleaching. This process does not depend on the visual cycle via the pigment epithelium but nevertheless enables rhodopsin molecules to absorb the critical number of photons required to induce retinal degeneration.
This article has been cited by other articles:
![]() |
H. Song, M. Belcastro, E. J. Young, and M. Sokolov Compartment-specific Phosphorylation of Phosducin in Rods Underlies Adaptation to Various Levels of Illumination J. Biol. Chem., August 10, 2007; 282(32): 23613 - 23621. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. White, W. W. Hauswirth, S. Kaushal, and A. S. Lewin Increased Sensitivity to Light-Induced Damage in a Mouse Model of Autosomal Dominant Retinal Disease Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1942 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Laabich, G. P. Vissvesvaran, K. L. Lieu, K. Murata, T. E. McGinn, C. C. Manmoto, J. R. Sinclair, I. Karliga, D. W. Leung, A. Fawzi, et al. Protective Effect of Crocin against Blue Light- and White Light-Mediated Photoreceptor Cell Death in Bovine and Primate Retinal Primary Cell Culture. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3156 - 3163. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Reme The Dark Side of Light: Rhodopsin and the Silent Death of Vision The Proctor Lecture Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2672 - 2682. [Full Text] [PDF] |
||||
![]() |
A. Wenzel, C. Grimm, M. Samardzija, and C. E. Reme The Genetic Modifier Rpe65Leu450: Effect on Light Damage Susceptibility in c-Fos-Deficient Mice Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2798 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Gordon, D. M. Casey, W. J. Lukiw, and N. G. Bazan DNA Damage and Repair in Light-Induced Photoreceptor Degeneration Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3511 - 3521. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishizawa, R. Pidikiti, P. A. Liebman, and R. G. Eckenhoff G Protein-Coupled Receptors as Direct Targets of Inhaled Anesthetics Mol. Pharmacol., May 1, 2002; 61(5): 945 - 952. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |